Who Paid My Doc
GelPOINT V-Path
Device Specialty Access
PDI 00607915138493
General payments
$2,447,331
Research payments
$0
Through program year 2025, $2,447,331 in general payments and $0 in research payments were reported against GelPOINT V-Path (Specialty Access).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $312,775 | 293 |
| 2024 | General | $362,566 | 377 |
| 2023 | General | $493,665 | 531 |
| 2022 | General | $600,039 | 712 |
| 2021 | General | $678,287 | 703 |
Breakdown
The top 5 of 80 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,616 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.